🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Netherlands
Clinical trial register · European Union · CTIS

Clinical Trials in Netherlands

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2500 most recently authorised of 12445 total CTIS records — a stated recency window, not the full historical archive. Synced 20 Sep 2026, 03:17 UTC
2500
Shown in this register
most recently authorised
12,445
Total on CTIS
full historical archive
745
Phase III
within the shown window
Top member states
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524
Narrow the registerReset
Phase
Phase I 558 Phase I/II 214 Phase II 726 Phase III 745 Phase IV 257
Lead sponsor
AstraZeneca AB 60 Assistance Publique Hopitaux De Paris 49 Merck Sharp & Dohme LLC 48 Pfizer Inc. 45 Novo Nordisk A/S 42
Member state
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524 Belgium 426 Czechia 327
All 28 states
95 of 2500 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase I
SAR447971 first-in-human study
2026-525333-22-00Hidradenitis
Sanofi-Aventis Recherche & Developpement
Immune System Diseases
Netherlands
20/05/2026
Phase I
A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease
2024-517310-15-00Parkinson's Disease
Mission Therapeutics Limited
Nervous System Diseases
Germany, Netherlands, France
18/05/2026
Phase I
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
2026-525590-40-00human immunodeficiency virus (HIV)
Viiv Healthcare UK Limited
Immune System Diseases
Netherlands
18/05/2026
Phase I
Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives
2025-524052-58-00Healthy Overweight or Obese
F. Hoffmann-La Roche AG
Nutritional and Metabolic Diseases
Netherlands
15/05/2026
Phase I
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167
2026-526096-31-00Chronic Heart Failure
Corteria Pharmaceuticals
Cardiovascular Diseases
Netherlands
13/05/2026
Phase I
A research study to see how NNC0487-0111 affects the body’s energy use after a weight loss in adults living with obesity, compared to a low-calorie diet or placebo
2025-522744-40-00Obesity
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Netherlands, Denmark
11/05/2026
Phase I
A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4771261 in healthy participants aged 25 to 55 years of age inclusive
2025-525073-37-00Autosomal Dominant Polycystic Kidney Disease
Glaxosmithkline Research & Development Limited
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Netherlands
06/05/2026
Phase I
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS
2026-525517-31-00Not applicable, healthy volunteers
InflaRx GmbH
Not possible to specify
Netherlands
01/05/2026
Phase I
A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune mediated diseases.
2026-525575-22-00Psoriasis
Klear Bio Inc.
Skin and Connective Tissue Diseases
Netherlands
30/04/2026
Phase I
A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients with bacterial infection
2026-525619-15-00Bacterial Infection
Centauri Therapeutics Limited
Bacterial Infections and Mycoses
Netherlands
30/04/2026
Phase I
A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL DOSE OF [14C]-VAFIDEMSTAT IN HEALTHY MALE PARTICIPANTS
2025-524832-20-00Healthy volunteers
Oryzon Genomics S.A.
Not possible to specify
Netherlands
30/04/2026
Phase I
Effect of NBI-921355 on corticospinal excitability in healthy participants
2025-524134-26-00Epilepsy
Neurocrine Biosciences Inc.
Nervous System Diseases
Netherlands
29/04/2026
Phase I
A Phase 1 Study of AIR-001 in Adults with AATD.
2025-523558-14-00Alpha-1 Antitrypsin Deficiency
Airna Corp.
Respiratory Tract Diseases
Sweden, Ireland, Spain, Netherlands, Portugal, Germany
17/04/2026
Phase I
A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people
2025-525025-12-00Iron overload from thalassemia, transfusion-dependent myelo…
Pharmacosmos A/S
Hemic and Lymphatic Diseases
Netherlands
07/04/2026
Phase I
A First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MR-L45 in Healthy Adults
2025-524899-40-00Autosomal Dominant Polycystic Kidney Disease
Mironid Limited
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Netherlands
01/04/2026
Phase I
Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia
2025-522617-39-00Refractory hyperlipidemia
Verve Therapeutics Inc.
Cardiovascular Diseases
Netherlands
30/03/2026
Phase I
Peri-operative intraperitoneal irinotecan and systemic FLOT in the curative treatment of gastric cancer and gastroesophageal junction cancer: a phase I study
2025-522864-34-00Gastric cancer
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Neoplasms
Netherlands
16/03/2026
Phase I
Safety and Preliminary Efficacy of CTX112 in Adult Participants with Relapsed/Refractory Hematologic Autoimmune Disease
2025-523845-90-00Relapsed/Refractory Hematologic Autoimmune Disease
CRISPR Therapeutics AG
Hemic and Lymphatic Diseases
Spain, Germany, France, Denmark, Italy, Netherlands
12/03/2026
Phase I
A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of obesity
2025-524856-73-00Not Applicable
F. Hoffmann-La Roche AG
Population Characteristics
Netherlands
11/03/2026
Phase I
A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease
2025-524693-42-00Stable Coronary Artery Disease (CAD)
F. Hoffmann-La Roche AG
Cardiovascular Diseases
Netherlands
06/03/2026
Phase I
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of LTP001 following a single oral dose of [14C]LTP001 in healthy male participants
2025-524172-29-00Healthy volunteers
Novartis Pharma AG
Not possible to specify
Netherlands
06/03/2026
Phase I
Phase 1 Single Ascending and Multiple Ascending Dose Study with LCA-0321
2025-524053-14-00Graves Disease
Lycia Therapeutics Inc.
Immune System Diseases
Netherlands
06/03/2026
Phase I
A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic peripheral neuropathy
2025-524258-32-00Diabetic Peripheral Neuropathy (DPN)
Tenvie Therapeutics Inc.
Musculoskeletal and Neural Physiological Phenomena
Netherlands
24/02/2026
Phase I
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Disease
2025-523515-11-00Early Alzheimer's Disease
Denali Therapeutics Inc.
Nervous System Diseases
Netherlands
18/02/2026
Phase I
A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes
2025-524210-28-00Not Applicable
F. Hoffmann-La Roche AG
Population Characteristics
Netherlands
11/02/2026
Rows per page Showing 26–50 of 95
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 20 September 2026. https://priyalifescience.com/clinical-trials-europe/country/netherlands

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.